Healthcare -
Biotechnology - NASDAQ - US
$ 4.43
-1.56 %
$ 376 M
Market Cap
-3.75
P/E
TERN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TERN - Terns Pharmaceuticals, Inc.
42 M
LAST VALUE
-44.13%
2 YEAR CAGR
-15.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR